Key Segmentation
By Technology
-
Next-Generation Sequencing (NGS)
-
Single-Cell Sequencing
-
PCR-Based Sequencing
-
Others
By Application
-
Cancer Research
-
Infectious Disease
-
Autoimmune Disorders
-
Vaccine Development
-
Others
By Sequencing Type
-
T-Cell Receptor (TCR)
-
B-Cell Receptor (BCR)
-
Others
By End User
-
Research Institutes
-
Hospitals & Clinics
-
Pharmaceutical & Biotechnology Companies
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market is expected to reach USD 1029.75 Million by 2035.
The market size was estimated at USD 369.93 Million in 2025.
The market is projected to grow at a CAGR of 10.78% during the forecast period.
North America is expected to dominate due to strong healthcare infrastructure and research funding.
Increasing demand for precision medicine, cancer immunotherapy, and advanced sequencing technologies are driving market growth.